All lobbying filings

Brownstein Hyatt Farber Schreck, LLP

Brownstein Hyatt Farber Schreck, LLP filed a Q1 report for Pierre Fabre Pharmaceuticals Inc. on April 15, 2026, reporting $20,000 in lobbying income.

Lobbying for Pierre Fabre Pharmaceuticals Inc. · Pharmaceutical manufacturer

As filed: BROWNSTEIN HYATT FARBER SCHRECK, LLP for PIERRE FABRE PHARMACEUTICALS INC.

All filings by Brownstein Hyatt Farber Schreck, LLP · Everything Pierre Fabre Pharmaceuticals Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 15, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Issues related to drug development, rare disease innovations, and issues impacting the pharmaceutical industry.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.